TC
LMAT icon

TFS Capital’s LeMaitre Vascular LMAT Stock Holding History

TFS Capital’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-19,317
Closed -$603K – 202
2017
Q2 		$603K Sell
19,317
-4,970
-20% -$144K 0.24% 139
2017
Q1 		$598K Sell
24,287
-29,281
-55% -$687K 0.19% 164
2016
Q4 		$1.36M Buy
53,568
+23,384
+77% +$519K 0.36% 74
2016
Q3 		$599K Sell
30,184
-53,989
-64% -$943K 0.14% 208
2016
Q2 		$1.2M Sell
84,173
-9,627
-10% -$147K 0.22% 132
2016
Q1 		$1.46M Sell
93,800
-82,537
-47% -$1.18M 0.21% 146
2015
Q4 		$3.04M Buy
176,337
+80,245
+84% +$1.16M 0.33% 79
2015
Q3 		$1.17M Buy
96,092
+3,902
+4% +$50K 0.11% 300
2015
Q2 		$1.11M Buy
+92,190
New +$907K 0.11% 306

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TFS Capital's LMAT Position: Q3 2017 in Review

TFS Capital sold out of LeMaitre Vascular (LMAT) in Q3 2017, closing a stake of 19,317 shares — an estimated $603K sold.

TFS Capital first reported a position in LMAT in Q2 2015 and held it in 9 quarters. The position peaked at $3.04M in Q4 2015. 148 funds tracked by Wall St. Rank hold LMAT as of Q3 2017.

  • TFS Capital reported no remaining LeMaitre Vascular position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 19,317 LeMaitre Vascular shares in Q3 2017, an estimated $603K.
  • TFS Capital first reported a position in LeMaitre Vascular in Q2 2015 and held it in 9 quarters.
  • TFS Capital's LeMaitre Vascular position peaked at $3.04M in Q4 2015.
  • 148 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.